Curis Up on Immuno-Oncology Agreement with Aurigene
Curis, Inc. ( CRIS ) announced that it has entered into an exclusive collaboration agreement with Aurigene Discovery Technologies Limited, an independent, wholly owned subsidiary of Dr. Reddy's Laboratories Ltd. […]